MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 228 filers reported holding MIRATI THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.34 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $21,567,198 | -29.4% | 475,992 | +8.8% | 0.01% | -37.5% |
| Q3 2022 | $30,564,079 | +10.0% | 437,630 | +5.7% | 0.01% | +14.3% |
| Q2 2022 | $27,791,082 | -14.6% | 413,989 | +4.6% | 0.01% | 0.0% |
| Q1 2022 | $32,536,427 | -44.0% | 395,724 | 0.0% | 0.01% | -41.7% |
| Q4 2021 | $58,049,000 | -7.7% | 395,724 | +11.3% | 0.01% | -14.3% |
| Q3 2021 | $62,918,000 | +5.9% | 355,647 | -3.3% | 0.01% | +7.7% |
| Q2 2021 | $59,437,000 | -11.0% | 367,962 | -5.7% | 0.01% | -13.3% |
| Q1 2021 | $66,817,000 | -31.9% | 390,056 | -12.6% | 0.02% | -34.8% |
| Q4 2020 | $98,067,000 | +28.2% | 446,490 | -3.1% | 0.02% | +15.0% |
| Q3 2020 | $76,476,000 | +49.5% | 460,560 | +2.8% | 0.02% | +33.3% |
| Q2 2020 | $51,151,000 | +70.9% | 448,025 | +15.0% | 0.02% | +36.4% |
| Q1 2020 | $29,937,000 | -33.9% | 389,450 | +10.9% | 0.01% | -15.4% |
| Q4 2019 | $45,258,000 | +160.3% | 351,216 | +57.4% | 0.01% | +160.0% |
| Q3 2019 | $17,385,000 | – | 223,136 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |